InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Sunday, 10/09/2016 11:16:33 AM

Sunday, October 09, 2016 11:16:33 AM

Post# of 6035
Bristol's Opdivo Disappoints in Lung Cancer, Losing Ground To Rival Merck
http://www.forbes.com/sites/matthewherper/2016/10/09/bristols-cancer-drug-results-are-worse-than-expected-while-mercks-are-better/#79b888595d9a

BMY needs HTBX badly.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News